Loading organizations...
TS Investment Corp operates as a South Korean venture capital firm, providing investment management and advisory services. It backs high-growth small and medium-sized enterprises across diverse sectors. Key areas include information technology, biotechnology, consumer goods, and manufacturing, fostering innovation and accelerating market expansion for its portfolio companies.
Founded in 2008, TS Investment Corp was established by Wung Kim, who leads as President, CEO, and Executive Director. The firm originated from the insight that promising South Korean enterprises required strategic capital and expert guidance to scale effectively. This foundational premise drives its role as a "value-adding partner" for developing ventures.
TS Investment Corp primarily serves innovative early-stage and expanding companies seeking capital and strategic collaboration. Its vision is to catalyze economic growth by actively building value within its investment portfolio. The firm empowers partners to navigate market conditions and achieve sustainable success, strengthening the entrepreneurial ecosystem.
TS Investment has 6 tracked investments across 6 companies. The latest tracked deal is $41.8M Series B in Illimis Therapeutics in July 2025.